Verition Fund Management
RPRX icon

Verition Fund Management’s Royalty Pharma RPRX Stock Holding History

Verition Fund Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,500
Closed -$265K – 3881
2025
Q3 		$265K Buy
+7,500
New +$272K ﹤0.01% 3356

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Verition Fund Management's RPRX Position: Q2 2026 in Review

Verition Fund Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 75,000 shares worth $4.21M. The stake represents 0.02% of the portfolio and ranks #729 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in RPRX as recently as Q4 2025.

Verition Fund Management first reported a position in RPRX in Q1 2021 and has held it in 20 quarters since. The position peaked at $10.6M in Q3 2025. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Verition Fund Management held 75,000 shares of Royalty Pharma worth $4.21M as of Q2 2026.
  • Royalty Pharma was a new Verition Fund Management position in Q2 2026.
  • Royalty Pharma made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #729 holding.
  • Verition Fund Management first reported a position in Royalty Pharma in Q1 2021 and has held it in 20 quarters since.
  • Verition Fund Management's Royalty Pharma position peaked at $10.6M in Q3 2025.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.